Thursday, October 08, 2020 11:17:34 AM
Research and Development
Chembio is committed to developing highly accurate, affordable, efficient point-of-care rapid test products to help prevent the spread of infectious diseases worldwide. Chembio has been a key OEM provider to global brands in the diagnostic industry for many years, and our experienced management and R&D teams are constantly looking for ways to provide innovative solutions for healthcare providers everywhere.
Currently, we partner with not only commercial organizations but also foundations, NGOs, and healthcare organizations to research and develop faster, more accurate rapid diagnostic devices. Our work focuses on the areas of HIV, STDs and TB, and other Infectious Diseases all which have established Chembio as one of the cutting-edge companies in the medical diagnostic assay industry.
http://chembio.com/innovation/research-and-development/
Recent CEMI News
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
